Use Authorisations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Use authorisations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Use Authorisations Today - Breaking & Trending Today

Letter: Sars-CoV2

Vaccinations of the young Dear Editor, Mark Hilliard’s Covid Q+A in the Irish Times (27/7/21) contains a very interesting number, i.e. the risk to the ....

William Ralph , Mark Hilliard Covid , Irish Times , Use Authorisations , வில்லியம் ரால்ப் , ஐரிஷ் முறை ,

Expect WHO Nod To Covaxin In July-Sept, Says Bharat Biotech Amid Travel Fears

Expect WHO Nod To Covaxin In July-Sept, Says Bharat Biotech Amid Travel Fears
Indiatimes
4 days ago
© Provided by Indiatimes
Vaccine developer Bharat Biotech said it expects approval for its Covid-19 vaccine Covaxin from the World Health Organisation (WHO) for emergency use listing (EUL) by July-September.
Approvals in process in over 60 nations
The company said regulatory approvals for Covaxin are in process in more than 60 countries including the USA, Brazil and Hungary among others. With this, Covaxin became the second India-made vaccine to apply at the global health agency for authorisation.
© Provided by Indiatimes
BCCL
Regulatory approvals for Covaxin are in process in over 60 countries. Emergency Use Authorisations have been obtained in 13 countries with more to follow, the Indian vaccine manufacturer said in a release. ....

United States , World Health Organisation , Bharat Biotech , Use Authorisations , ஒன்றுபட்டது மாநிலங்களில் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , பாரத் பயோடெக் ,

Phase 3 interim results of Covaxin released - The Hindu BusinessLine

Phase 3 interim results of Covaxin released
April 21, 2021
Clinical efficacy at 78%; 100% efficacy against severe Covid-19 disease: Bharat Biotech
Bharat Biotech has announced Phase 3 interim analysis results of Covaxin, following a second interim analysis based on 87 symptomatic cases of Covid-19. Due to the recent surge in cases, 127 symptomatic cases were recorded, resulting in a point estimate of vaccine efficacy of 78 per centagainst mild, moderate, and severe Covid-19 disease.
The efficacy against severe Covid-19 disease was 100 per cent, with an impact on reduction in hospitalisations. The efficacy against asymptomatic Covid-19 infection was 70 per cent, suggesting decreased transmission in Covaxin recipients.
Safety and efficacy results from the final analysis will be available in June, and the final report will be submitted to a peer-reviewed publication. Based on the achievement of the success criteria, placebo recipients have now become eligible to ....

Andhra Pradesh , White House , District Of Columbia , United States , Krishna Ella , Balram Bhargava , Suchitra Ella , National Institute Of Virology , Team Bharat Biotech , Indian Council Of Medical Research , Health Research , Bharat Biotech , National Institute , Indian Council , Medical Research , Managing Director , Director General , Emergency Use Authorisation , Joint Managing Director , Use Authorisations , Phase 3 Interim Results , Asymptomatic Cases , Covid 19 , Human Clinical Trials , ஆந்திரா பிரதேஷ் , வெள்ளை வீடு ,

Govt will consider vaccine third dose as booster next year, says Khairy

Govt will consider vaccine third dose as booster next year, says Khairy
thesundaily.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thesundaily.my Daily Mail and Mail on Sunday newspapers.

Negeri Sembilan , Khairy Jamaluddin , National Covid , National Pharmaceutical Regulatory Division , Immunisation Programme , Coordinating Minister , Rembau Hospital , Innovation Minister , Pfizer Biontech , Use Authorisations , கைரி ஜமாலுதீன் , தேசிய மருந்து ஒழுங்குமுறை பிரிவு , நோய்த்தடுப்பு ப்ரோக்ராம் , ஒருங்கிணைத்தல் அமைச்சர் , கண்டுபிடிப்பு அமைச்சர் ,